Peptide therapy before and after
What outcomes does the research show, how long do they take, and what does a structured peptide therapy program look like? Here is an evidence-based overview.
Educational research tools — not medical advice.
What is a peptide therapy program?
A peptide therapy program is a structured protocol prescribed by a licensed provider — typically a telehealth clinic, integrative medicine physician, or compounding pharmacy — that specifies which peptide(s) to use, the dose, injection frequency, route, and total duration. Most programs run 3–6 months with periodic labs to track relevant biomarkers.
Programs are goal-specific. A body composition protocol (GH secretagogues) looks very different from a recovery protocol (BPC-157, TB-500) or a cognitive protocol (Semax, Selank). A provider typically orders baseline labs before prescribing and reassesses at 6–12 weeks.
Note: Most peptides used in clinical programs are research compounds without FDA approval for specific indications. Sermorelin and tesamorelin are exceptions with prior regulatory history. No peptide therapy program constitutes FDA-approved medical treatment unless otherwise specified.
Research outcomes by goal
Findings from published preclinical and clinical research — not therapeutic claims.
Body composition
8–16 weeksGH secretagogue trials in GH-deficient adults documented significant increases in lean body mass and reductions in visceral fat at 6 months. Tesamorelin RCT data (FDA submission) showed 17–18% visceral fat reduction at 26 weeks vs placebo. Individual results depend heavily on baseline GH status, diet, and exercise.
Recovery & tissue repair
4–12 weeksBPC-157 preclinical data shows accelerated tendon and ligament healing, reduced inflammation, and muscle recovery across multiple injury models. TB-500 promotes actin polymerization and cellular migration critical to wound healing. GHK-Cu upregulates collagen synthesis genes and extracellular matrix remodeling. All are research compounds with no human clinical trial approval.
Sleep quality
1–4 weeksGH secretagogues increase slow-wave sleep (SWS) duration — the stage during which endogenous GH peaks. Research subjects on ipamorelin protocols report improved sleep onset and deeper rest. DSIP (delta sleep-inducing peptide) was originally isolated from rabbit brain sleep plasma and studied directly for sleep-promoting effects. Epitalon research (Khavinson protocols) documented circadian rhythm normalization in aging populations.
Skin & collagen
6–12 weeksGHK-Cu (copper tripeptide) is among the most studied peptides for dermal applications, with published data on collagen and elastin upregulation, wound healing, and anti-inflammatory activity at the skin level. Topical and subcutaneous routes are both studied. BPC-157 research includes dermal wound closure models. Results appear at 6–12 weeks in most trial designs.
Cognitive function
4–8 weeksSemax (ACTH fragment) and Selank (tuftsin analog) are researched in Russia for BDNF upregulation and anxiety modulation respectively. Noopept is studied for neuroprotective and cognitive-enhancing effects in animal models. Cerebrolysin (a neurotrophic factor mixture) has undergone clinical trials for post-stroke cognitive recovery in Eastern European registries. Western clinical data remains limited.
Typical program timeline
Weeks 1–2
Lab baseline, first injections, protocol orientation
Subjective: sleep changes, energy shifts (variable by person)
Weeks 3–8
Consistent dosing, protocol adjustment if needed
Early recovery changes; sleep improvement common in GH protocols
Months 2–3
Mid-protocol lab draw (IGF-1, relevant biomarkers)
Body composition changes begin to be measurable in GH protocols; skin changes visible in collagen-targeting protocols
Months 4–6
Full protocol assessment; continuation or cycling decision
Primary outcome assessment; lab comparison to baseline
Frequently asked questions
How long before peptide therapy shows results?
Timeline varies by peptide and goal. Sleep improvement is often reported within 1–2 weeks on GH secretagogue protocols. Body composition changes typically require 8–12 weeks to be measurable. Skin and collagen outcomes from GHK-Cu protocols are generally assessed at 3 months.
Is peptide therapy the same as HGH therapy?
No. Most peptide therapy programs use growth hormone secretagogues — compounds that signal the pituitary to release endogenous GH — not synthetic human growth hormone (HGH). Secretagogues preserve the body's natural pulsatile GH rhythm and typically cost significantly less than pharmaceutical HGH.
What labs are checked before starting a program?
Baseline labs depend on the protocol goal. GH secretagogue programs typically include IGF-1, fasting glucose, and a metabolic panel. Recovery-focused protocols may include inflammatory markers (CRP, ESR). A prescribing provider determines which labs are appropriate for the individual.
What does peptide therapy cost?
Price ranges by peptide type, provider, and program length.
HGH peptides explained
How GH secretagogues differ from synthetic HGH — mechanism, cost, and research.
Find a peptide therapy provider
Browse verified clinics, telehealth platforms, and compounding pharmacies on PeptideBase. Filter by location, peptide, and provider type.
Browse the directory